找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Ethical Innovation for Global Health; Pandemic, Democracy Chieko Kurihara,Dirceu Greco,Ames Dhai Book 2023 The Editor(s) (if applicable) a

[复制链接]
楼主: Jefferson
发表于 2025-3-23 10:27:30 | 显示全部楼层
Ethics of Placebo-Controlled Trials: Historical Analysis Including Experiences During the COVID-19 Pn bioethics. Since the onset of the HIV/AIDS pandemic in the 1980s, the issue of placebo-controlled trials after the discovery of efficacious drugs for HIV in the mid-1990s has sparked international controversy. This topic needs to be revisited with the experiences accumulated during the COVID-19 pa
发表于 2025-3-23 14:33:57 | 显示全部楼层
Post-Trial Access: Historical Analysis Considering the Experience of COVID-19 Pandemictroversy at the end of the 1990s on clinical trials to overcome the HIV/AIDS pandemic. This ethical principle was drawn upon out of concern that sponsor companies would conduct placebo-controlled trials in resource poor countries that could not be conducted in wealthier parts of the world, and that
发表于 2025-3-23 22:00:09 | 显示全部楼层
Our “WMA Declaration of Helsinki”: Opinions and Proposals from Patient and Public for Research Ethic with the latest version being adopted in 2013. While it has been incorporated into research regulations in many countries and is well known to most researchers, most patients and the public see its title for the first time when they are requested to participate in medical research. We therefore for
发表于 2025-3-24 01:29:39 | 显示全部楼层
发表于 2025-3-24 04:22:00 | 显示全部楼层
Development of Portfolios and Pipelines of Drugs for the Treatment, Prevention and Control of Neglech treatment and control measures have been developed. Product development partnerships (PDPs) have been established to bring forward new tools for these efforts. A huge movement, including international organizations, academia, pharmaceutical and biotech sectors, committed to advancing the treatment
发表于 2025-3-24 07:22:32 | 显示全部楼层
Patient and Public Involvement (PPI) and Pharmaceutical Development Through Open Innovation Processevolvement activity started in the AIDS drug development programs. Reflecting the accumulated efforts of internationally active NPOs and other organizations, patient voices are now expanded in the drug development process. During the COVID-19 pandemic, new approaches, such as decentralized clinical t
发表于 2025-3-24 13:59:30 | 显示全部楼层
发表于 2025-3-24 14:55:21 | 显示全部楼层
发表于 2025-3-24 21:14:49 | 显示全部楼层
https://doi.org/10.1007/978-1-4684-5278-5al access and the use of placebos—are arguably more relevant than ever in light of the COVID-19 pandemic and the clinical trials for vaccines that were performed in an expedited manner. These and other issues must be examined regularly to ensure the continued applicability of this core WMA document.
发表于 2025-3-24 23:17:34 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-20 14:06
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表